WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017058895) AMYLOID BETA DETECTION BY MASS SPECTROMETRY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/058895    International Application No.:    PCT/US2016/054148
Publication Date: 06.04.2017 International Filing Date: 28.09.2016
IPC:
G01N 33/68 (2006.01), B01D 15/26 (2006.01)
Applicants: QUEST DIAGNOSTICS INVESTMENTS LLC [US/US]; 3 Giralda Farms Madison, New Jersey 07940 (US)
Inventors: TRAN, Diana; (US).
WEBER, Darren; (US).
CLARKE, Nigel; (US)
Agent: QUEST DIAGNOSTICS INVESTMENTS LLC; 3 Giralda Farms Madison, New Jersey 07940 (US).
LOMPREY, Jeffrey; (US).
MEARA, Joseph; (US).
KALAFUT, Christopher; (US)
Priority Data:
62/234,027 28.09.2015 US
62/277,772 12.01.2016 US
Title (EN) AMYLOID BETA DETECTION BY MASS SPECTROMETRY
(FR) DÉTECTION DE BÊTA-AMYLOÏDE PAR SPECTROMÉTRIE DE MASSE
Abstract: front page image
(EN)Provided are methods for the detection or quantitation of amyloid beta. In a particular aspect, provided herein are methods for detecting amyloid beta or fragments thereof by mass spectrometry. In another aspect, provided herein are methods for determining the ratio of amyloid beta 42 (Αβ42) to amyloid beta 40 (Αβ40). In another aspect, provided herein are methods for diagnosis or prognosis of Alzheimer's disease or dementia.
(FR)L'invention concerne des procédés de détection ou de quantification de bêta-amyloïde. Dans un aspect particulier, la présente invention concerne des procédés de détection de bêta-amyloïde ou de fragments de celle-ci par spectrométrie de masse. Dans un autre aspect, l'invention concerne des procédés de détermination du rapport de la bêta-amyloïde 42 (Αβ42) à la bêta-amyloïde 40 (Αβ40). Dans un autre aspect, l'invention concerne des méthodes pour le diagnostic ou le pronostic de la maladie d'Alzheimer ou la démence.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)